ACHV 3.69 (-3.4%)
US0044685008BiotechnologyBiotechnology

Achieve Life Sciences (ACHV) Stock Highlights

3.69 | -3.4%
2024-12-21 06:32:01
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieves focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.

Statistics

Range Today
3.6 3.96
Volume Today 477K
Range 1 Year
3.2 5.59
Volume 1 Year 34.63M
Range 3 Year
2 10.3
Volume 3 Year 76.28M
Range 10 Year
2 9020
Volume 10 Year 196.76M

Highlights

Market Capitalization 159M (small)
Floating Shares 32.58M
Current Price 3.69
Price To Earnings -4.42
Price To Book 5.08
Earnings Per Share -1.07
Payout Ratio 0%

Performance

Latest -3.4%
1 Month -15.56%
3 Months -18.54%
6 Months -21.82%
1 Year +6.96%
3 Years -48.46%
5 Years -63.1%
10 Years -99.92%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.